The Week in Review: Safety News Dominates

July 15, 2007 – The execution of former head of the Chinese FDA, Zheng Xiaoyu, for bribery was the big story last week in the world of Chinese biotech. This takes place against the backdrop of the upcoming Olympics, which were supposed to showcase China as a fully modern nation. In a public relations counter-offensive, China was careful to make a well-publicized show of remedial steps. Meanwhile, results from investments made in the second quarter show that more and more deals are getting done in China. Given the financial logic of biotech investing in China, the latter may be the more important story. More details...